Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingrid Pabinger

Showing results (141-150 of 367) with videos related to

Pageof 37
Sort By:
Blood Advances|March 7, 2019
High risk of adverse pregnancy outcomes in women with a persistent lupus anticoagulantJohanna Gebhart, Florian Posch, Silvia Koder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2011
Prediction of venous thromboembolism in patients with cancer by measuring thrombin generation: results from the Vienna Cancer and Thrombosis StudyCihan Ay, Daniela Dunkler, Ralph Simanek, et al.
Thrombosis and Haemostasis|March 1, 2005
Basal high-sensitivity-C-reactive protein levels in patients with spontaneous venous thromboembolismRainer Vormittag, Thomas Vukovich, Verena Schönauer, et al.
Thrombosis and Haemostasis|May 6, 2006
Interleukin-6 and interleukin-6 promoter polymorphism (-174) G > C in patients with spontaneous venous thromboembolismRainer Vormittag, Kety Hsieh, Alexandra Kaider, et al.
Haematologica|November 4, 2005
Haptoglobin phenotype 2-2 as a potentially new risk factor for spontaneous venous thromboembolismRainer Vormittag, Thomas Vukovich, Christine Mannhalter, et al.
Haematologica|August 2, 2007
Risk of recurrence after a first venous thromboembolic event in young womenClarissa Laczkovics, Helga Grafenhofer, Alexandra Kaider, et al.
Thrombosis Research|February 9, 2023
Association of telomere length and mitochondrial DNA copy number, two biomarkers of biological aging, with the risk of venous thromboembolismRafaela Vostatek, Philipp Hohensinner, Stephan Nopp, et al.
Research and Practice in Thrombosis and Haemostasis|June 17, 2025
Clonal hematopoiesis in patients with cancer and its association with risk of thrombosis and prognosis of diseaseCornelia Englisch, Roland Jäger, Jasmina Gassner, et al.
Haematologica|October 12, 2023
Tissue factor pathway inhibitor is associated with risk of venous thromboembolism and all-cause mortality in patients with cancerCornelia Englisch, Florian Moik, Johannes Thaler, et al.
Research and Practice in Thrombosis and Haemostasis|August 4, 2023
Extended half-life factor IX prophylaxis up to every 21 days in hemophilia B: a longitudinal analysis of the efficacy and safety in selected adult patientsIngrid Pabinger, Toshko Lissitchkov, Asuza Nagao, et al.
Pageof 37

Showing results (141-150 of 367) with videos related to

Sort By:
Pageof 37
Blood Advances|March 7, 2019
High risk of adverse pregnancy outcomes in women with a persistent lupus anticoagulantJohanna Gebhart, Florian Posch, Silvia Koder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2011
Prediction of venous thromboembolism in patients with cancer by measuring thrombin generation: results from the Vienna Cancer and Thrombosis StudyCihan Ay, Daniela Dunkler, Ralph Simanek, et al.
Thrombosis and Haemostasis|March 1, 2005
Basal high-sensitivity-C-reactive protein levels in patients with spontaneous venous thromboembolismRainer Vormittag, Thomas Vukovich, Verena Schönauer, et al.
Thrombosis and Haemostasis|May 6, 2006
Interleukin-6 and interleukin-6 promoter polymorphism (-174) G > C in patients with spontaneous venous thromboembolismRainer Vormittag, Kety Hsieh, Alexandra Kaider, et al.
Haematologica|November 4, 2005
Haptoglobin phenotype 2-2 as a potentially new risk factor for spontaneous venous thromboembolismRainer Vormittag, Thomas Vukovich, Christine Mannhalter, et al.
Haematologica|August 2, 2007
Risk of recurrence after a first venous thromboembolic event in young womenClarissa Laczkovics, Helga Grafenhofer, Alexandra Kaider, et al.
Thrombosis Research|February 9, 2023
Association of telomere length and mitochondrial DNA copy number, two biomarkers of biological aging, with the risk of venous thromboembolismRafaela Vostatek, Philipp Hohensinner, Stephan Nopp, et al.
Research and Practice in Thrombosis and Haemostasis|June 17, 2025
Clonal hematopoiesis in patients with cancer and its association with risk of thrombosis and prognosis of diseaseCornelia Englisch, Roland Jäger, Jasmina Gassner, et al.
Haematologica|October 12, 2023
Tissue factor pathway inhibitor is associated with risk of venous thromboembolism and all-cause mortality in patients with cancerCornelia Englisch, Florian Moik, Johannes Thaler, et al.
Research and Practice in Thrombosis and Haemostasis|August 4, 2023
Extended half-life factor IX prophylaxis up to every 21 days in hemophilia B: a longitudinal analysis of the efficacy and safety in selected adult patientsIngrid Pabinger, Toshko Lissitchkov, Asuza Nagao, et al.
Pageof 37